Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 62.63M | $ 470K | 0.75% |
3/31/2025 | $ 68.32M | $ 554K | 0.81% |
12/31/2024 | $ 76.39M | $ 643K | 0.84% |
9/30/2024 | $ 88.75M | $ 799K | 0.9% |
6/30/2024 | $ 96.13M | $ 866K | 0.9% |
3/31/2024 | $ 55.94M | $ 972K | 1.74% |
12/31/2023 | $ 66.5M | $ 1.09M | 1.64% |
6/30/2023 | $ 100.8M | $ 31.06M | 30.81% |
12/31/2022 | $ 110.1M | $ 30.14M | 27.38% |
6/30/2022 | $ 135.04M | $ 30.14M | 22.32% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for MEREO BIOPHARMA GROUP PLC is calculated as follows: Intangibles [ $ 39.56M ] / Assets [ $ 78.68M ]
(=) Intang. to Assets [ 50.28% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.24K |
---|---|
min | 0% |
max | 23.16% |
average | 3.98% |
median | 0.52% |
std | 6.09% |